Evidence map›Paper›PMID 26793196›Full record

ReviewFrontiers in immunology2015

Gene Association with Leprosy: A Review of Published Data.

Priscila Saamara Mazini, Hugo Vicentin Alves, Pâmela Guimarães Reis, Ana Paula Lopes, Ana Maria Sell, Manuel Santos-Rosa, Jeane Eliete Laguila Visentainer, Paulo Rodrigues-Santos

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Impact of the Polymorphism of theIranian journal of medical sciences · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Frontiers in immunology · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Association between NDO-LID and PGL-1 for leprosy and class I and II human leukocyte antigen alleles in an indigenous community in Southwest Amazon.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Priscila Saamara MaziniFaculty of Medicine, Immunology Institute, University of Coimbra, Coimbra, Portugal; Immunogenetics Laboratory, Department of Basic Health Sciences, Maringá State University, Maringá, Paraná, Brazil.
Hugo Vicentin AlvesImmunogenetics Laboratory, Department of Basic Health Sciences, Maringá State University , Maringá, Paraná , Brazil.
Pâmela Guimarães ReisImmunogenetics Laboratory, Department of Basic Health Sciences, Maringá State University , Maringá, Paraná , Brazil.
Ana Paula LopesImmunogenetics Laboratory, Department of Basic Health Sciences, Maringá State University , Maringá, Paraná , Brazil.
Ana Maria SellImmunogenetics Laboratory, Department of Basic Health Sciences, Maringá State University , Maringá, Paraná , Brazil.
Manuel Santos-RosaFaculty of Medicine, Immunology Institute, University of Coimbra, Coimbra, Portugal; Immunology and Oncology Laboratory, Center for Neurosciences and Cell Biology, University of Coimbra, Coimbra, Portugal.
Jeane Eliete Laguila VisentainerImmunogenetics Laboratory, Department of Basic Health Sciences, Maringá State University , Maringá, Paraná , Brazil.
Paulo Rodrigues-SantosFaculty of Medicine, Immunology Institute, University of Coimbra, Coimbra, Portugal; Immunology and Oncology Laboratory, Center for Neurosciences and Cell Biology, University of Coimbra, Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leprosy is a chronic infectious disease caused by an obligate intracellular bacterium known as Mycobacterium leprae. Exposure to the bacillus is necessary, but this alone does not mean an individual will develop clinical symptoms of the disease. In recent years, several genes have been associated with leprosy and the innate immune response pathways converge on the main hypothesis that genes are involved in the susceptibility for the disease in two distinct steps: for leprosy per se and in the development of the different clinical forms. These genes participate in the sensing, main metabolic pathway of immune response activation and, subsequently, on the evolution of the disease into its clinical forms. The aim of this review is to highlight the role of innate immune response in the context of leprosy, stressing their participation in the signaling and targeting processes in response to bacillus infection and on the evolution to the clinical forms of the disease.

Indexed as

immune response genesinnate immunityleprosyMycobacterium leprae

Identifiers

PMID26793196
PMCPMC4709443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.